View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Hear CCO faculty Philip Newsome discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Philip N. Newsome, PhD, FRCPE
Released: February 12, 2020
CCO faculty Dr Juan Frias discusses the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Juan Pablo Frias, MD, FACE
Released: February 5, 2020
Juan Frias and Philip Newsome: Learn about the agents in phase II and III clinical trials and their potential use in treatment.
Juan Pablo Frias, MD, FACE
Philip N. Newsome, PhD, FRCPE
Released: January 28, 2020
Hear CCO faculty Rita Basu, MD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests
Rita Basu, MD
Released: January 23, 2020
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
